Cyclopamine increases the radiosensitivity of human pancreatic cancer cells by regulating the DNA repair signal pathway through an epidermal growth factor receptor-dependent pathway

16Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Pancreatic cancer is an aggressive malignancy with a characteristic metastatic course of disease and resistance to conventional radiotherapy. As a result, the continual development of novel therapeutic agents is required to improve the current situation. In the present study, the effect of the hedgehog pathway inhibitor, cyclopamine, on cellular radiosensitivity was determined in K-RASwt Colo-357 and K-RASmt SW-1990 human pancreatic cancer cell lines using the clonogenic survival assay. Apoptosis and cell cycle distribution were detected using flow cytometry assay. Following irradiation (30 mins), residual double-strand breaks were quantified by identification of ?-H2AX foci of micronuclei and radiation-induced ?-H2AX, p-ATM, DNA-PKcs and Ku70 expression was analyzed using western blot analysis. The epidermal growth factor (EGF) and EGF receptor (EGFR) inhibitor, gefitinib, were utilized to determine the related mechanisms. The results revealed that cyclopamine treatment significantly reduced cell clonogenic survival but failed to induce apoptosis and radiation-induced G2 arrest. Flow cytometry revealed that cyclopamine treatment enhanced ?-H2AX foci in Colo-357 and SW-1990 cells exposed to irradiation. In addition, radiation-induced p-ATM, DNA-PKcs and Ku70 were all inhibited. EGF also rescued pancreatic cancer cells from cyclopamine-induced H2AX phosphorylation following irradiation. Thus, cyclopamine enhanced the radiosensitivity of human pancreatic cancer cells, in part, through an EGFR-dependent pathway, indicating a rational approach in combination with radiotherapy.

References Powered by Scopus

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1999Citations
N/AReaders
Get full text

Pancreatic cancer

630Citations
N/AReaders
Get full text

Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers

627Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells

125Citations
N/AReaders
Get full text

Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles

35Citations
N/AReaders
Get full text

Radiation sensitization of basal cell and head and neck squamous cell carcinoma by the hedgehog pathway inhibitor vismodegib

33Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wu, X. Y., Che, J., Sun, K. K., Shen, X. J., Yang, D., Zhong, N., & Zhao, H. (2013). Cyclopamine increases the radiosensitivity of human pancreatic cancer cells by regulating the DNA repair signal pathway through an epidermal growth factor receptor-dependent pathway. Molecular Medicine Reports, 8(4), 979–983. https://doi.org/10.3892/mmr.2013.1605

Readers over time

‘15‘16‘18‘19‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

73%

Researcher 2

18%

Lecturer / Post doc 1

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

69%

Biochemistry, Genetics and Molecular Bi... 3

23%

Neuroscience 1

8%

Save time finding and organizing research with Mendeley

Sign up for free
0